Page last updated: 2024-09-05

isobavachin and allopurinol

isobavachin has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(isobavachin)
Trials
(isobavachin)
Recent Studies (post-2010)
(isobavachin)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
120815,0967433,363

Protein Interaction Comparison

ProteinTaxonomyisobavachin (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Chen, Y; Li, L; Li, Y; Liao, H; Lin, C; Luo, J; Pang, J; Tian, J; Tian, Y; Wu, T; Yang, Y; Zhang, Q; Zhang, S; Zhao, K; Zhao, Z; Zheng, F1

Other Studies

1 other study(ies) available for isobavachin and allopurinol

ArticleYear
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
    Bioorganic chemistry, 2023, Volume: 133

    Topics: Animals; Flavones; Kidney; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase

2023